Computed tomography-derived body composition and early changes predict outcomes of first-line chemo-immunotherapy in recurrent/metastatic nasopharyngeal carcinoma
The Oncologist · 2026
DOI: 10.1093/oncolo/oyag355 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Oncologist, 2026. Verfasst von Xia Gan und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, C…. Hauptthemen laut MEDLINE: Body Composition, Tomography, X-Ray Computed, Nasopharyngeal Carcinoma, Neoplasm Recurrence, Local. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Hunan Province, Scientific Research Project of Hunan Provincial Health Commission, Health Research Project of Hunan Provincial Health Commission.
Abstract (Originalsprache)
Background
Reliable biomarkers for risk stratification and treatment monitoring in recurrent/metastatic nasopharyngeal carcinoma (R/M NPC) treated with first-line chemo-immunotherapy remain limited. This study evaluated the prognostic value of baseline computed tomography (CT)-derived body composition parameters and their early dynamic changes.
Methods
In this single-center retrospective cohort study, patients with R/M NPC receiving first-line chemo-immunotherapy were included. The primary endpoint was progression-free survival (PFS), and secondary endpoints included overall survival (OS), objective response rate (ORR), and disease control rate (DCR). Associations between body composition and outcomes were analyzed.
Results
A total of 199 patients were included, and 99 with post-treatment CT after 2 cycles were further analyzed for dynamic changes. Higher baseline skeletal muscle area (SMA) was independently associated with longer PFS (HR = 0.56; 95% CI, 0.37-0.85; P = 0.006) and OS (HR = 0.46; 95% CI, 0.23-0.93; P = 0.03), and with higher ORR (82.8% vs 70.0%; P = 0.033) and DCR (98.0% vs 91.0%; P = .031). During early treatment, a ≤1.3% decrease or an increase in SMA was independently associated with longer PFS (HR = 0.53; P = 0.045) and OS (HR = 0.27; P = 0.018). A greater decline in visceral adipose tissue density (ΔVATD < −0.9%) was also associated with more favorable PFS and OS, whereas no significant difference in ORR was observed.
Conclusion
Baseline SMA and early changes in SMA and VATD have prognostic value in R/M NPC treated with first-line chemo-immunotherapy. CT-based body composition assessment may serve as a practical imaging biomarker for risk re-stratification and individualized management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiation Oncology, Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, 410013, China.
- Hunan Key Laboratory of Translational Radiation Oncology, Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, 410013, China.
ORCID-Profile: Zhengzheng Yu, Huai Liu
Förderung
- Natural Science Foundation of Hunan Province
- Scientific Research Project of Hunan Provincial Health Commission
- Health Research Project of Hunan Provincial Health Commission
- High-Level Talent Scientific Research
Zitieren
APA
Gan, X., Yu, Z., Tang, Y., Zhang, L., Xie, W., Sun, X., Li, Y., Fang, J., Liu, Y., Liu, Z., Zhou, C., Xie, Z., Yao, W., Ouyang, S., Zhang, J., Wang, J., Li, H., Chen, P., Wang, H., …, & Liu, H. (2026). Computed tomography-derived body composition and early changes predict outcomes of first-line chemo-immunotherapy in recurrent/metastatic nasopharyngeal carcinoma. The Oncologist. https://doi.org/10.1093/oncolo/oyag355
Vancouver
Gan X, Yu Z, Tang Y, Zhang L, Xie W, Sun X, et al. Computed tomography-derived body composition and early changes predict outcomes of first-line chemo-immunotherapy in recurrent/metastatic nasopharyngeal carcinoma. The Oncologist. 2026. doi:10.1093/oncolo/oyag355
BibTeX
@article{Gan2026,
author = {Gan, Xia and Yu, Zhengzheng and Tang, Yaning and Zhang, Lin and Xie, Wenji and Sun, Xiaowen and Li, Yue and Fang, Jianing and Liu, Yating and Liu, Zhongjie and Zhou, Can and Xie, Zhuolong and Yao, Wen and Ouyang, Shuyu and Zhang, Jing and Wang, Jingyu and Li, Hua and Chen, Pan and Wang, Hui and Li, Yanxian and Liu, Huai},
title = {Computed tomography-derived body composition and early changes predict outcomes of first-line chemo-immunotherapy in recurrent/metastatic nasopharyngeal carcinoma},
journal = {The Oncologist},
year = {2026},
doi = {10.1093/oncolo/oyag355}
}
EUVIMED